L. Fredrik Jarskog

8.4k total citations
94 papers, 6.1k citations indexed

About

L. Fredrik Jarskog is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, L. Fredrik Jarskog has authored 94 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Psychiatry and Mental health, 24 papers in Cellular and Molecular Neuroscience and 19 papers in Cognitive Neuroscience. Recurrent topics in L. Fredrik Jarskog's work include Schizophrenia research and treatment (30 papers), Neuroscience and Neuropharmacology Research (15 papers) and Infant Health and Development (9 papers). L. Fredrik Jarskog is often cited by papers focused on Schizophrenia research and treatment (30 papers), Neuroscience and Neuropharmacology Research (15 papers) and Infant Health and Development (9 papers). L. Fredrik Jarskog collaborates with scholars based in United States, Australia and Japan. L. Fredrik Jarskog's co-authors include John H. Gilmore, Jeffrey A. Lieberman, Leisa A. Glantz, Seiya Miyamoto, Swarooparani Vadlamudi, Jean M. Lauder, Nobumi Miyake, W.W. Fleischhacker, Diana O. Perkins and David L. Penn and has published in prestigious journals such as NeuroImage, American Journal of Psychiatry and Neurology.

In The Last Decade

L. Fredrik Jarskog

91 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Fredrik Jarskog United States 40 1.5k 1.4k 1.2k 1.0k 935 94 6.1k
Tiago Reis Marques United Kingdom 37 2.2k 1.5× 939 0.7× 1.1k 0.9× 360 0.4× 1.3k 1.4× 112 5.5k
Henrik Dobrowolny Germany 29 925 0.6× 742 0.5× 798 0.7× 699 0.7× 2.0k 2.1× 122 5.0k
Andreas Papassotiropoulos Switzerland 50 1.1k 0.7× 2.5k 1.8× 1.2k 1.0× 567 0.6× 1.6k 1.7× 173 8.5k
Robert P. McMahon United States 58 2.6k 1.7× 1.4k 1.0× 960 0.8× 578 0.6× 1.8k 2.0× 180 11.5k
Bart P. F. Rutten Netherlands 48 1.9k 1.3× 2.7k 2.0× 1.2k 1.1× 923 0.9× 875 0.9× 243 9.3k
Ina Giegling Germany 39 1.2k 0.8× 1.3k 1.0× 1.1k 1.0× 374 0.4× 1.1k 1.2× 133 5.0k
Jerzy Samochowiec Poland 36 1.3k 0.9× 1.3k 0.9× 1.3k 1.1× 308 0.3× 517 0.6× 321 5.4k
James B. Lohr United States 50 2.6k 1.7× 870 0.6× 911 0.8× 498 0.5× 1.3k 1.4× 139 7.1k
Toshiyuki Someya Japan 38 1.5k 1.0× 1.1k 0.8× 1.1k 1.0× 478 0.5× 1.1k 1.2× 281 5.9k
Rodrigo A. Bressan Brazil 47 2.8k 1.9× 866 0.6× 1.2k 1.0× 542 0.5× 1.8k 1.9× 379 7.9k

Countries citing papers authored by L. Fredrik Jarskog

Since Specialization
Citations

This map shows the geographic impact of L. Fredrik Jarskog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Fredrik Jarskog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Fredrik Jarskog more than expected).

Fields of papers citing papers by L. Fredrik Jarskog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Fredrik Jarskog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Fredrik Jarskog. The network helps show where L. Fredrik Jarskog may publish in the future.

Co-authorship network of co-authors of L. Fredrik Jarskog

This figure shows the co-authorship network connecting the top 25 collaborators of L. Fredrik Jarskog. A scholar is included among the top collaborators of L. Fredrik Jarskog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Fredrik Jarskog. L. Fredrik Jarskog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kimhy, David, Luz H. Ospina, Melanie M. Wall, et al.. (2025). Telehealth-Based vs In-Person Aerobic Exercise in Individuals With Schizophrenia: Comparative Analysis of Feasibility, Safety, and Efficacy. JMIR Mental Health. 12. e68251–e68251.
2.
Stephens, Rebecca, et al.. (2024). Early cognitive development and psychopathology in children at familial high risk for schizophrenia. Schizophrenia Research. 271. 262–270. 1 indexed citations
3.
Browne, Julia, Cláudio L. Battaglini, L. Fredrik Jarskog, et al.. (2021). Targeting physical health in schizophrenia: Results from the Physical Activity Can Enhance Life (PACE-Life) 24-week open trial. Mental health and physical activity. 20. 100393–100393. 9 indexed citations
4.
Harvey, Philip D., et al.. (2019). Autism symptoms, depression, and active social avoidance in schizophrenia: Association with self-reports and informant assessments of everyday functioning. Journal of Psychiatric Research. 115. 36–42. 52 indexed citations
5.
Jones, Mackenzie T., et al.. (2019). Confidence, performance, and accuracy of self-assessment of social cognition: A comparison of schizophrenia patients and healthy controls. Schizophrenia Research Cognition. 19. 100133–100133. 43 indexed citations
6.
Ludwig, Kelsey, Grace Lee Simmons, L. Fredrik Jarskog, et al.. (2019). Correlates of loneliness among persons with psychotic disorders. Social Psychiatry and Psychiatric Epidemiology. 55(5). 549–559. 29 indexed citations
7.
Fernandez, Hubert H., David Stamler, Mat D. Davis, et al.. (2018). Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-Label Extension Study (P4.075). Neurology. 90(15_supplement). 1 indexed citations
8.
Jarskog, L. Fredrik & T. Scott Stroup. (2018). 261. Metformin and 5-HT2C Agonist Lorcaserin for Weight Loss in Schizophrenia. Biological Psychiatry. 83(9). S105–S106. 2 indexed citations
9.
Barch, Deanna M., Stephen R. Marder, Michael P. Harms, et al.. (2016). Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 71. 66–75. 9 indexed citations
10.
Frӧhlich, Flavio, et al.. (2016). Exploratory study of once-daily transcranial direct current stimulation (tDCS) as a treatment for auditory hallucinations in schizophrenia. European Psychiatry. 33(1). 54–60. 74 indexed citations
11.
Miyake, Nobumi, Seiya Miyamoto, & L. Fredrik Jarskog. (2012). New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia. Clinical Schizophrenia & Related Psychoses. 6(3). 122–133. 13 indexed citations
12.
Kayser, Jürgen, Craig E. Tenke, Christopher J. Kroppmann, et al.. (2012). A neurophysiological deficit in early visual processing in schizophrenia patients with auditory hallucinations. Psychophysiology. 49(9). 1168–1178. 21 indexed citations
13.
Jarskog, L. Fredrik, et al.. (2010). Adolescent with Treatment-Refractory Schizophrenia and Clozapine-Induced Cardiomyopathy Managed with High-Dose Olanzapine. Journal of Child and Adolescent Psychopharmacology. 20(6). 539–543. 8 indexed citations
14.
Henson, Maile A., Adam C. Roberts, Kayvon Salimi, et al.. (2008). Developmental Regulation of the NMDA Receptor Subunits, NR3A and NR1, in Human Prefrontal Cortex. Cerebral Cortex. 18(11). 2560–2573. 86 indexed citations
15.
Jarskog, L. Fredrik, Seiya Miyamoto, & Jeffrey A. Lieberman. (2007). Schizophrenia: New Pathological Insights and Therapies. Annual Review of Medicine. 58(1). 49–61. 83 indexed citations
16.
Perkins, Diana O., Clark Jeffries, L. Fredrik Jarskog, et al.. (2007). microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome biology. 8(2). R27–R27. 446 indexed citations
17.
Jarskog, L. Fredrik & Jeffrey A. Lieberman. (2006). Neuroprotection in Schizophrenia. The Journal of Clinical Psychiatry. 67(9). e09–e09. 77 indexed citations
18.
Gilmore, John H., L. Fredrik Jarskog, & Swarooparani Vadlamudi. (2004). Maternal poly I:C exposure during pregnancy regulates TNFα, BDNF, and NGF expression in neonatal brain and the maternal–fetal unit of the rat. Journal of Neuroimmunology. 159(1-2). 106–112. 148 indexed citations
19.
Jarskog, L. Fredrik, et al.. (2000). Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia. Biological Psychiatry. 48(7). 641–650. 140 indexed citations
20.
Jarskog, L. Fredrik & John H. Gilmore. (1996). Cytokine regulation of apoptosis in fetal substantia nigra cultures. Biological Psychiatry. 39(7). 582–582. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026